Prostate Cancer Treatment - CanAmHIFU

About Us

Can-Am HIFU, a private clinic located in Toronto, Ontario, specializes in High Intensity Focused Ultrasound therapy. Can-Am HIFU is a Canadian entity of International HIFU , a healthcare development company and medical device distributor headquartered in Charlotte, N.C.

HIFU with the Sonablate® 500 has been approved by Health Canada for the treatment of prostate cancer since June 2005. HIFU is an alternative treatment option to External Beam Radiation, Watchful Waiting, Radical Prostatectomy, Brachytherapy, Cryosurgery, Hormone Therapy and Chemotherapy.

The medical team at Can-Am HIFU includes seven urological surgeons: Jack Barkin, MD; Laurence Klotz, MD; Sender Herschorn, MD; Neil Fleshner, MD; Michael Robinette, MD; Sidney Radomski, MD; and Antonio Finelli, MD. The centre’s staff also includes registered nurses and MD anesthetists.

Can-Am HIFU is committed to improving patients’ quality of life by changing the way prostate cancer care is delivered.

ADDRESS
Can-Am HIFU
984 Bay St Ste 502
Toronto, ON Canada M5S 2A5

Toll Free: 1-877-787-5906

[ Back ]

Disclaimer

IMPORTANT INFORMATION:
The Sonablate® 500 is not approved for use in the U.S. The Sonablate® 500 remains investigational in the U.S. and is being studied for the treatment of prostate cancer in clinical trialsin the U.S. FDA has made no decision as to the safety or efficacy of the Sonablate® 500 for the treatment of prostate cancer. Currently, the device is approved for the treatment of prostate cancer in Canada and the Dominican Republic, authorized in Argentina, and available in the Bahamas and Mexico.
If the Sonablate® 500 is approved by the FDA for use in the U.S., there is no assurance that instructions for use or the specifications of the device will be the same as the device and treatment approved or authorized in other countries outside of the U.S.